Skip to main content
Top
Published in: Immunologic Research 2-3/2009

01-12-2009

Omental immune aggregates and tumor metastasis within the peritoneal cavity

Authors: Elizabeth W. Sorensen, Scott A. Gerber, Abigail L. Sedlacek, Viktoriya Y. Rybalko, Winnie M. Chan, Edith M. Lord

Published in: Immunologic Research | Issue 2-3/2009

Login to get access

Abstract

The omentum, an important peritoneal tissue, is studded with a high number of immune aggregates, or “milky spots,” the number, function, and phenotype of which is largely unknown. We have analyzed the immune composition on the normal omentum and also have shown that both free immune cells and tumor cells in the peritoneal fluid bind preferentially to these immune aggregates. This binding may be mediated by the network of collagen I fibers, which overlay these areas. In addition, we have shown that not only do omental vessels express vascular endothelial growth factor receptor 3 (VEGFR3), a receptor that is only found on angiogenic blood vessels, but that tumor cells co-localize with these vessels, possibly increasing the ability of tumor to induce neovascularization and therefore thrive.
Literature
2.
go back to reference Ozols RF, Bookman MA, Connolly DC, Daly MB, Godwin AK, Schilder RJ, et al. Focus on epithelial ovarian cancer. Cancer Cell. 2004;5:19–24.CrossRefPubMed Ozols RF, Bookman MA, Connolly DC, Daly MB, Godwin AK, Schilder RJ, et al. Focus on epithelial ovarian cancer. Cancer Cell. 2004;5:19–24.CrossRefPubMed
3.
go back to reference Krist LF, Eestermans IL, Steenbergen JJ, Hoefsmit EC, Cuesta MA, Meyer S, et al. Cellular composition of milky spots in the human greater omentum: an immunochemical and ultrastructural study. Anat Rec. 1995;241:163–74.CrossRefPubMed Krist LF, Eestermans IL, Steenbergen JJ, Hoefsmit EC, Cuesta MA, Meyer S, et al. Cellular composition of milky spots in the human greater omentum: an immunochemical and ultrastructural study. Anat Rec. 1995;241:163–74.CrossRefPubMed
4.
go back to reference Gerber SA, Rybalko VY, Bigelow CE, Lugade AA, Foster TH, Frelinger JG, et al. Preferential attachment of peritoneal tumor metastases to omental immune aggregates and possible role of a unique vascular microenvironment in metastatic survival and growth. Am J Pathol. 2006;169:1739–52.CrossRefPubMed Gerber SA, Rybalko VY, Bigelow CE, Lugade AA, Foster TH, Frelinger JG, et al. Preferential attachment of peritoneal tumor metastases to omental immune aggregates and possible role of a unique vascular microenvironment in metastatic survival and growth. Am J Pathol. 2006;169:1739–52.CrossRefPubMed
5.
go back to reference Ranvier H. Du developpement t de l’accroissement des vaisseaux sanguins. Arch Physiol. 1874;1:429. Ranvier H. Du developpement t de l’accroissement des vaisseaux sanguins. Arch Physiol. 1874;1:429.
6.
go back to reference Shimotsuma M, Shields JW, Simpson-Morgan MW, Sakuyama A, Shirasu M, Hagiwara A, et al. Morpho-physiological function and role of omental milky spots as omentum-associated lymphoid tissue (OALT) in the peritoneal cavity. Lymphology. 1993;26:90–101.PubMed Shimotsuma M, Shields JW, Simpson-Morgan MW, Sakuyama A, Shirasu M, Hagiwara A, et al. Morpho-physiological function and role of omental milky spots as omentum-associated lymphoid tissue (OALT) in the peritoneal cavity. Lymphology. 1993;26:90–101.PubMed
7.
go back to reference Roby KF, Taylor CC, Sweetwood JP, Cheng Y, Pace JL, Tawfik O, et al. Development of a syngeneic mouse model for events related to ovarian cancer. Carcinogenesis. 2000;21:585–91.CrossRefPubMed Roby KF, Taylor CC, Sweetwood JP, Cheng Y, Pace JL, Tawfik O, et al. Development of a syngeneic mouse model for events related to ovarian cancer. Carcinogenesis. 2000;21:585–91.CrossRefPubMed
8.
go back to reference Gerber SA, Moran JP, Frelinger JG, Frelinger JA, Fenton BM, Lord EM. Mechanism of IL-12 mediated alterations in tumour blood vessel morphology: analysis using whole-tissue mounts. Br J Cancer. 2003;88:1453–61.CrossRefPubMed Gerber SA, Moran JP, Frelinger JG, Frelinger JA, Fenton BM, Lord EM. Mechanism of IL-12 mediated alterations in tumour blood vessel morphology: analysis using whole-tissue mounts. Br J Cancer. 2003;88:1453–61.CrossRefPubMed
9.
11.
go back to reference Kearney JF, Bartels J, Hamilton AM, Lehuen A, Solvason N, Vakil M. Development and function of the early B cell repertoire. Int Rev Immunol. 1992;8:247–57.CrossRefPubMed Kearney JF, Bartels J, Hamilton AM, Lehuen A, Solvason N, Vakil M. Development and function of the early B cell repertoire. Int Rev Immunol. 1992;8:247–57.CrossRefPubMed
12.
go back to reference Resendizz-Albor AA, Esquivel R, Lopez-Revilla R, Verdin L, Moreno-Fierros L. Striding phenotypic and functional differences in lamina propria lymphocytes from the large and small intestine of mice. Life Sci. 2005;76:2783–803.CrossRef Resendizz-Albor AA, Esquivel R, Lopez-Revilla R, Verdin L, Moreno-Fierros L. Striding phenotypic and functional differences in lamina propria lymphocytes from the large and small intestine of mice. Life Sci. 2005;76:2783–803.CrossRef
13.
go back to reference Seibold F, Seibold-Schmid B, Cong Y, Shu FY, McCabe R, Weaver C, et al. Regional differences in L-selectin expression in murine intestinal lymphocytes. Gastroenterology. 1998;114:965–74.CrossRefPubMed Seibold F, Seibold-Schmid B, Cong Y, Shu FY, McCabe R, Weaver C, et al. Regional differences in L-selectin expression in murine intestinal lymphocytes. Gastroenterology. 1998;114:965–74.CrossRefPubMed
14.
go back to reference Wang L, Jackson WC, Steinbach PA, Tsien RY. Evolution of new nonantibody proteins via iterative somatic hypermutation. Proc Natl Acad Sci USA. 2004;101:16745–9.CrossRefPubMed Wang L, Jackson WC, Steinbach PA, Tsien RY. Evolution of new nonantibody proteins via iterative somatic hypermutation. Proc Natl Acad Sci USA. 2004;101:16745–9.CrossRefPubMed
15.
go back to reference Beelen RH. The greater omentum: physiology and immunological concepts. Neth J Surg. 1991;43:145–9.PubMed Beelen RH. The greater omentum: physiology and immunological concepts. Neth J Surg. 1991;43:145–9.PubMed
16.
go back to reference Freedman RS, Tomasovic B, Templin S, Atkinson EN, Kudelka A, Edwards CL, et al. Large-scale expansion in interleukin-2 of tumor-infiltrating lymphocytes from patients with ovarian carcinoma for adoptive immunotherapy. J Immunol Methods. 1994;167:145–60.CrossRefPubMed Freedman RS, Tomasovic B, Templin S, Atkinson EN, Kudelka A, Edwards CL, et al. Large-scale expansion in interleukin-2 of tumor-infiltrating lymphocytes from patients with ovarian carcinoma for adoptive immunotherapy. J Immunol Methods. 1994;167:145–60.CrossRefPubMed
17.
go back to reference Ioannides CG, Platsoucas CD, Rashed S, Wharton JT, Edwards CL, Freedman RS. Tumor cytolysis by lymphocytes infiltrating ovarian malignant ascites. Cancer Res. 1991;51:4257–65.PubMed Ioannides CG, Platsoucas CD, Rashed S, Wharton JT, Edwards CL, Freedman RS. Tumor cytolysis by lymphocytes infiltrating ovarian malignant ascites. Cancer Res. 1991;51:4257–65.PubMed
18.
go back to reference Paavonen K, Puolakkainen P, Jussila L, Jahkola T, Alitalo K. Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing. Am J Pathol. 2000;156:1499–504.PubMed Paavonen K, Puolakkainen P, Jussila L, Jahkola T, Alitalo K. Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing. Am J Pathol. 2000;156:1499–504.PubMed
19.
go back to reference Partanen TA, Alitalo K, Miettinen M. Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors. Cancer. 1999;86:2406–12.CrossRefPubMed Partanen TA, Alitalo K, Miettinen M. Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors. Cancer. 1999;86:2406–12.CrossRefPubMed
20.
go back to reference Clarijs R, Schalkwijk L, Hofmann UB, Ruiter DJ, de Waal RM. Induction of vascular endothelial growth factor receptor-3 expression on tumor microvasculature as a new progression marker in human cutaneous melanoma. Cancer Res. 2002;62:7059–65.PubMed Clarijs R, Schalkwijk L, Hofmann UB, Ruiter DJ, de Waal RM. Induction of vascular endothelial growth factor receptor-3 expression on tumor microvasculature as a new progression marker in human cutaneous melanoma. Cancer Res. 2002;62:7059–65.PubMed
21.
go back to reference Longatto Filho A, Martins A, Costa SM, Schmitt FC. VEGFR-3 expression in breast cancer tissue is not restricted to lymphatic vessels. Pathol Res Pract. 2005;201:93–9.CrossRefPubMed Longatto Filho A, Martins A, Costa SM, Schmitt FC. VEGFR-3 expression in breast cancer tissue is not restricted to lymphatic vessels. Pathol Res Pract. 2005;201:93–9.CrossRefPubMed
Metadata
Title
Omental immune aggregates and tumor metastasis within the peritoneal cavity
Authors
Elizabeth W. Sorensen
Scott A. Gerber
Abigail L. Sedlacek
Viktoriya Y. Rybalko
Winnie M. Chan
Edith M. Lord
Publication date
01-12-2009
Publisher
Humana Press Inc
Published in
Immunologic Research / Issue 2-3/2009
Print ISSN: 0257-277X
Electronic ISSN: 1559-0755
DOI
https://doi.org/10.1007/s12026-009-8100-2

Other articles of this Issue 2-3/2009

Immunologic Research 2-3/2009 Go to the issue